Human Growth Hormone Market Analysis

Human Growth Hormone Industry Insights

Product Type Insights

The short-acting category is the larger, with a share of 65% in 2024. The use cases of SAGHs are well-established, and this variant has been known for a longer time than its long-acting counterpart. Moreover, acting over short durations, this variant needs to be administered more frequently, which makes is a more-repetitive purchase. Additionally, more patented and generic variants of SAGHs are available compared to LAGHs.

LAGHs will account for the higher CAGR, of 15.5%, during 2024–2030. In many countries, daily recombinant HGH is currently approved for adults and children with a growth hormone deficiency, as it has few side-effects. Daily injections, on the other hand, can be uncomfortable and stressful for certain patients, thus leading to non-adherence and poor treatment results. This has led to the development of a number of LAGH therapies, which allow for a lower injection frequency, such as weekly, bi-weekly, or monthly. These analogs could potentially improve patient acceptance, tolerance, and treatment versatility; thus, they will be preferred in the long run.

The following product types have been analyzed:

• Short-Acting (Larger Category)
• Long-Acting (Faster-Growing Category)

Indication Insights

Turner syndrome accounts for the major market share, of 40%, in 2024. Turner syndrome is a female-specific chromosomal disease characterized by the deletion of one of the X chromosomes, either partially or completely. Symptoms include a receding or indistinct hairline and a wide neck, as well as a high blood pressure, mild eye difficulties, sagging eyelids, and an underactive thyroid gland. Turner syndrome affects about 1 in every 2,000–2,500 newly born females. It is estimated to influence around 70,000 females in the U.S.

Turner syndrome patients are more likely to contract the COVID-19 virus, which can cause serious sickness. They are also more likely to have congenital heart problems, such as a bicuspid aortic valve. Further, COVID-19 can cause significant consequences if there is an underlying medical issue, such as heart disease. Because Turner syndrome is linked to a slew of health difficulties, including heart disease, autoimmune illnesses, mental health issues, infertility, and hearing loss, pregnancy complications, apart from COVID-19, the demand for growth hormone treatments is rising.

Small for gestational age is the fastest-growing category, over this decade. This is attributed to the increasing awareness of this condition and its early diagnosis in children. Up to 15% of the children born around the world are small for gestational age, and many continue to show stunted growth even after the age of 3.

The report offers insights into the below-mentioned indications:

• Growth Hormone Deficiency
• Prader–Willi Syndrome
• Turner Syndrome (Largest Category)
• Small for Gestational Age (Fastest-Growing Category)
• Others

Distribution Channel Analysis

Hospital pharmacies account for the major market share, in 2024. This was due to the preference for synthetic or recombinant variants of this hormone and the ease with which it is available at hospital pharmacies. In addition, the rising awareness of growth hormone shortage, as well as the increasing volume of hospital visits for treatment, is predicted to propel the hospital pharmacy distribution channel sector forward.

Online pharmacies will have the highest CAGR during the forecast period, of 15.5%. This is attributed to the increasing popularity of e-commerce and growing trust in online pharmacies, which now ask for a signed doctor’s prescription before delivering medications. Online shopping has many well-known benefits, including promotional offers and discounts, detailed information on similar products of different brands, electronic payments, and doorstep delivery. Moreover, the COVID-19 pandemic has heightened people’s interest in avoiding the long queues at physical stores and shopping via their laptops and smartphones instead.

We have studied the following distribution channels:

• Hospital Pharmacy (Largest Category)
• Retail Pharmacy
• Online Pharmacy (Fastest-Growing Category)